Pasak bumi (PB) (Eurycoma longifolia Jack), is an Indonesian herb used as antimalarial. No research had been done before, of its effect on endogenous antioxidant enzyme. This study aims to investigate the antimalarial property of PB extract on the reduction of specific antioxidant enzyme. We used Plasmodium berghei infected mice, treated with: PB 30 (TI), 60 (TII), and 90 mg/kg BW (TIII), positive control (chloroquine 10 mg/kg BW) (KP), negative control (aquadest) (KN), normal mice control (K0). The parameters evaluated were: growth inhibition of parasite, carbonyl concentration, specific activity of SOD and CAT. Growth inhibition on day 7 of KP, TI, TII, and TIII were 69,81%, 39,37%, 41,72%, and 12,92%. Comparison of specific activity of plasma SOD and CAT showed insignificant differences between groups. Specific activity of liver SOD and liver CAT showed significant differences between groups. Carbonyl concentrations within groups of plasma and liver show insignificant differences. There is positive correlation between liver SOD with CAT specific activity (r = 0 690, p = 0 000), as well as negative correlation between liver SOD with paracytemia (r = −0 637, p = 0 000) and CAT specific activity with paracytemia (r = −0 557, p = 0 002). Therefore, the potential use of PB as an antimalarial was of doubtful effectiveness due to its antioxidant effect which could benefit the parasite.
INTRODUCTION
Pasak Bumi (PB) (Eurycoma longifolia Jack) is a herb that is known in Kalimantan. This plant has many bioactive components, including components with antimalarial and antioxidants properties. 1 During malarial infection, the growth of parasite and the production of ROS in malaria infected mice is directly correlated. 2 When the production of ROS increases, this will trigger oxidative damage, including lipid oxidation, protein oxidation, breakage of DNA "ribbon," modification of DNA bases, as well as modulation of gene expression. This is because a variety of protective antioxidant enzymes in cells and regulated metabolic processes which prevent cell damage become unbalanced and thus causing various diseases.
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This study, uses PB root extract as an antioxidant, related to the activity of SOD and catalase, with carbonyl compounds as biomarkers, and mice infected with P. berghei. The purpose of using extract of PB roots is to assess the potential of PB as an antimalarial by evaluating the decrease in the specific activity of the endogenous enzyme (SOD, catalase) in counteracting free radicals such as ROS which is caused by the Plasmodium berghei infection. 2 4 
METHOD
For the percentage inhibition of parasite growth by chloroquine (CQ) and Pasak Bumi (PB), refer to the 7-day test method. SOD is tested using RanSOD ® SD 125 kit. Catalase is tested using Mates method, whilst carbonyl is tested using Levine method. The average Parasitemia level for 7 days Fig. 1 . The average percentage of parasitemia in 1000 mouse erythrocytes for 7 days. Description: KN: Negative control (mouse+0 2 mL P. berghei+distilled water for 7 days). KP: Positive control (mouse + 0 2 mL P. berghei + dose of 10 mg CQ/kg BW for 3 days). TI: Treatment 1 (mouse + 0 2 mL P. berghei + 30 mg PB root extract/kg BW/day for 7 days). TII: Treatment 2 (mouse + 0 2 mL P. berghei + 60 mg PB root extract/kg BW/day for 7 days). TIII: Treatment 3 (mouse + 0 2 mL P. berghei + 90 mg PB root extract/kg BW/day for 7 days).
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RESULTS
Effects of PB root extract, containing 65% of active ingredients, on the degree of parasitaemia, can be observed through the number of parasitaemia in each treatment group. Below is the percentage proportion of parasitaemia in 1000 erythrocytes, Figure 1 . In Figure 1 , average percentage of parasitaemia on the 7th day in group TI, TII and TIII is 33.94%, 32.6%, 49.4%, whilst the positive control (KP) is 17.2%. Parasitaemia growth inhibition can be observed in graph 2 with the formula: % Inhibition = 100% − Xe/Xk × 100% Description: Xe: the average growth percentage of parasites which were given a specific dose of the test material. Xk: the average growth percentage of parasites of the negative control.
On Graph 2, the TI group of PB extracts on day 7 showed inhibition of the growth of the parasite by 39.37%, TII group by 41.72%, TIII group by 12.92%, and not significant (p > 0 05) with the treatment given. The specific activity of plasma SOD enzyme showed 2 522 ± 0 453 U/mg protein and was not significant (p > 0 05), whilst the specific activity of the liver SOD enzyme showed 254 771 ± 100 101 U/mg protein, and is significant (p < 0 05). Through the Post Hoc test, comparison of KP and TI, KP and KO, TI and KN, TII and KN, TIII and KN, as 
Treated groups
Activity Specific of SOD Liver well as KO and KN, revealed significant difference (p < 0 05), as shown in Figure 3 . Specific activity of the plasma catalase enzyme showed 0.000352 (0-0.00779) U/mg, which was not significant (p > 0 05); whilst the specific activity of the liver catalase enzyme showed 0.162 (0-0.841) U/mg protein which was significant (p < 0 05) as shown between the group KP and TI, KP and TII, KP and TIII, KP and KO, TI and TIII, TI and KN, TII and KN, KO and KN which were significant (p > 0 05).
Plasma and liver carbonyl compounds showed concentrations of 55.435 (0-797.818) nmol/mg protein and 3859.572 (0-20,268.42) nmol/mg protein which was not significant (p > 0 05). On day 7, there is a positive correlation between the specific activity of plasma SOD enzyme and plasma catalase, with r = 0 148 that is not significant (p > 0 05); whilst the specific activity of the liver SOD enzyme and liver catalase showed positive correlation, with r = 0 690 that is significant (p < 0 05), as shown in Figure 4 .
There is a positive correlation between the specific activity of the plasma SOD enzyme and plasma carbonyl with r = 0 082 that is not significant (p > 0 05); whilst there is negative correlation between the specific activity of liver SOD enzyme and liver carbonyl with r = −0 158 that is not significant (p > 0 05). There is positive correlation between the specific activity of the plasma catalase enzyme and plasma carbonyl with r = 0 033 that is not significant (p > 0 05); whilst there is negative correlation between specific activity of liver catalase enzyme and liver carbonyl, with r = −0 226 that is not significant (p > 0 05). There is positive correlation between specific enzyme activity of Plasma SOD and parasitaemia with r = 0 123 that is not significant (p > 0 05); whilst there is negative correlation between the specific activity of liver SOD enzyme and parasitaemia with r = −0 637 that is significant (p < 0 05), as shown in Figure 5 .
There is negative correlation between the specific activity of the plasma catalase enzyme and parasitaemia with r = −0 354 that is not significant (p > 0 05); whilst there is negative correlation between the specific activity of the liver catalase enzyme and parasitaemia with r = −0 557, that is significant (p < 0 05). 
DISCUSSION
The main components of PB extract include tannins, phenolics, flavonoids, alkaloids, triterpenoids and glycosides. Alkaloids inhibit hemozoin polymerization, whilst quasinoid compound, a member of triterpenoids class, plays a role in the inhibition of synthesis of nucleic acid and protein of P. falcifarum that is infecting human red blood cells. 4 5 In addition, alkaloid and quasinoid compounds has potential to be an antiplasmodial. 6 Quasinoid has a lower resistance profile compared to Choroquine, because Chloroquine does not have the ability to inhibit protein synthesis of the parasite. The antioxidants effect of Flavonoids also has antimalarial property by its ability to inhibit the NPP (New permeability Pathways) track of the parasite, which serve as transport channel for nutrients, and its ability to inhibit the hemoglobin degradation within the food vacuole of the parasite. 7 At the completion of this study, on day 7, the KP group that was given Chloroquine for 3 days showed 69.81% inhibition of parasitaemia, which was better than TI, TII and TIII that was treated PB root extract; it is thought that oral administration of PB contains level of bioactive compounds that is low, and hence it is unable to stop or eradicate the growth of the parasites. 8 The therapeutic activity of PB extract at 60 mg/kg BW (TII) has a mean parasite inhibition level of 41.74%, which is higher than the TI and TIII groups, though this is not exactly the same as the result from previous study which reported a 51% inhibition of the parasite with 60 mg/kg BW PB extract and 41% inhibition with 30 mg/kg BW dose. 9 It is thought that herbal extracts with antimalarial properties, also have a variety of other compounds with various mechanism of actions of specific bioactivity. 10 PB extract with a therapeutic dose of 90 mg/kg did not show any antimalarial potential, and it is thought that this dose may have toxic effect towards mice and causes increase in free radicals level which damages cells/tissues of mice. Researchers had previously given PB extract at therapeutic doses of 50 and 100 mg/kg BW intraperitoneally, but this prove to hasten the death of mice, when compared with dose of 30 mg/kg BW. 11 On the other hand, it is also thought that the active antioxidant compound within PB may actually provide nutrition for the Plasmodium to thrive and survive. 12 13 Other study had suggested that extract used in experimental treatment can be considered to possess antiplasmodial properties if it can reduce the level of parasitaemia by 30%. 12 Yusuf et al. performed in vitro study on active compounds eurycomanone which showed that it has antimalarial properties (IC50 = 2 04 ng/mL), and concluded that eurycomanone may potentially be used as antimalarial, 14 whilst other studies indicated that the bioavailability of oral administration of eurikomanon is not optimal; with its plasma concentration by oral administration of eurikomanon (as one of the quasinoid bioactive compound), being much lower than its plasma concentration by intravenous administration. 8 SOD and catalase are intracellular antioxidant enzymes, and it reduces free radicals to prevent cell damage by clearing the free radicals or ROS through enzymatic reaction and turn it into a more stable compound. SOD works by catalyzing dismutation reaction of free radical superoxide anion (O − 2 ), converting it into hydrogen peroxide and oxygen molecules which renders it harmless to the cell. 15 On the other hand, catalase works by capturing and breaking down free radicals by converting H 2 O 2 into H 2 O and O 2 and hence preventing the potential damage that may be caused by the free radical. 15 group (KO), the specific activity of the plasma SOD enzyme in the KP group increased whilst the other groups decreased. There is an increase in the specific activity of liver SOD enzymes and liver catalase, and it is thought that the activity of the liver SOD and liver catalase enzyme in counteracting the increase in free radicals is more marked than that in plasma, and in this regard the liver SOD and catalase showed statistically significant effect with PB extract therapy. The specific activity of the enzyme showed that there is high oxidative stress that occurs during the body's attempt to eliminate excess oxidants (free radicals), which was induced by the growth of the parasite that causes an increase in free radicals. This can be seen in the efficacy of the inhibition of the parasite on the 7th day in the TI group which amounted to only 39.37%, TII group 41.74% and TIII group 12.92%.
Administration of 30 mg/kg BW, 60 mg/kg BW, 90 mg/kg BW of PB extract therapy and chloroquine resulted in increase of the specific activity of the plasma catalase enzyme when compared to KO group (normal), and it is thought that the enzyme present in plasma comes from the overflow from organ which then accumulates, in contrast to the normal group. In the KP group, the role of Chloroquine as blood Schizontocide have a main working mechanism of blocking the formation of hemozoin from heme that originated from the digestion of hemoglobin by Plasmodium. Free heme can trigger formation of ROS which helps the elimination of Plasmodium in erythrocyte. 2 4 On other hand, if ROS occurs in excess, it can cause cellular damage.
Damage of protein as a result of ROS is revealed by the carbonyl compound marker. Antioxidant therapy of PB root extract is unable to inhibit the formation of carbonyl or lower the carbonyl levels as caused by infection of Plasmodium berghei. 18 From previous in vitro studies, phenolic compounds, such as quasinoid, was able to reduce free radicals, as shown by its ability to inhibit the carbonyl compounds, which is a marker of protein damage. 3 From this study, it is shown that the effect of PB root extract as an antimalarial at 30 mg/kg BW, 60 mg/kg dosage and the enzymatic activity of liver SOD and catalase revealed a reduction, however, it did not lower plasma SOD, plasma catalase, and carbonyl compounds. On the other hand, it appears that there is positive correlation which is significant between liver SOD and liver catalase, and a negative correlation which is not significant between liver SOD and liver catalase toward carbonyl as well as negative correlation which is significant between liver SOD and liver catalase toward parasitaemia. This indicates that there is coordinated response by liver SOD enzymes and liver catalase to work colaboratively to overcome and neutralize the free radicals in the liver. 16 All groups showed an increase in the carbonyl compound when compared to the control group (K), although the results were not statistically significant. It is thought that in the parasitic infections, the medication therapy of PB extract is not yet fully effective, because one of its bioactive compounds within the PB that is administered is present at very low level and does not represent the quantitative threshold that is required for a role as an antioxidant. 8 The significant positive correlation between liver SOD and liver catalase indicates that there is treatment efficacy with synergistic enzymatic action. The negative correlation of the specific enzyme activity with parasitaemia on 7th day were significant, indicating that there is efficacy of the therapy on the specific activity of the enzyme, which continuously counteract free radicals produced by the parasite. This research has not been able to show whether the molecules of the chemical components that has anti malaria properties is the same molecule as that which works as an antioxidant against malaria infection; and, whether the bioactive compounds within the PB root extract works synergistically or antagonistically. Moreover, it is not clear if the mechanism of PB extract as an antimalarial is through another metabolic pathway or is due to differences in the microenvironment of the liver and blood plasma. The other possibility, is that because P. berghei has to avoid ROS to ensure its survival, there occur antagonistic interaction between antimalarial compounds and the other antioxidant compound within the PB.
It is concluded that the potential of the root of pasak bumi (Eurycoma longifolia Jack) to be used as antimalarial is doubtful because this herb also has antioxidant properties which is beneficial to the parasite. The other reasons being that PB does not decreased the carbonyl levels of liver and plasma of mice infected with Plasmodium berghei; and that there is significant positive correlation between the specific activity of liver SOD enzymes and liver catalase, as well as a significant negative correlation between the specific activity of the liver SOD enzyme, and liver catalase with parasitaemia.
